BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22169728)

  • 1. [Propranolol in the treatment of problematic infantile hemangiomas].
    Lu J; Qin G; Huang J; Li S; Zhao J; Xiang Y; Chen J; Zuo C; Yang S; Tna L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Nov; 36(11):1102-5. PubMed ID: 22169728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].
    Qin ZP; Liu XJ; Li KL; Zhou Q; Yang XJ; Zheng JW
    Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3130-4. PubMed ID: 20193276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of infantile parotid hemangioma with propranolol].
    Liu XJ; Qin ZP; Tai MZ; Li KL; Ge CX
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 May; 45(5):292-4. PubMed ID: 20654246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of superficial infantile hemangiomas with topical propranolol].
    Niu JN; Xu GQ; Lü RR; Huo R
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Mar; 29(2):100-3. PubMed ID: 23772486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical propranolol for treatment of superficial infantile hemangiomas.
    Xu G; Lv R; Zhao Z; Huo R
    J Am Acad Dermatol; 2012 Dec; 67(6):1210-3. PubMed ID: 22516113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral propranolol: an effective, safe treatment for infantile hemangiomas.
    Zaher H; Rasheed H; Hegazy RA; Hegazy RA; Abdelhalim DM; Gawdat HI
    Eur J Dermatol; 2011; 21(4):558-63. PubMed ID: 21697036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results of propranolol treatment for patients with infantile hemangioma.
    Corapcioğlu F; Büyükkapu-Bay S; Binnetoğlu K; Babaoğlu A; Anik Y; Tugay M
    Turk J Pediatr; 2011; 53(2):137-41. PubMed ID: 21853649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants.
    Erbay A; Sarialioglu F; Malbora B; Yildirim SV; Varan B; Tarcan A; Gülcan H; Demir S; Derbent M; Uslu N; Abbasoğlu A
    Turk J Pediatr; 2010; 52(5):450-6. PubMed ID: 21434528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of propranolol gel on infantile hemangiomas].
    Zhai YN; Song HT; Chen SQ; Zhang MX; Li CJ; Xia Y; Wang L
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2013 Jan; 29(1):25-8. PubMed ID: 23600126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Propranolol for infantile hemangiomas.
    Bagazgoitia L; Torrelo A; Gutiérrez JC; Hernández-Martín A; Luna P; Gutiérrez M; Baño A; Tamariz A; Larralde M; Alvarez R; Pardo N; Baselga E
    Pediatr Dermatol; 2011; 28(2):108-14. PubMed ID: 21385205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Outcomes of Infants With Periorbital Hemangiomas Treated With Oral Propranolol.
    Xue L; Sun C; Xu DP; Liu ZM; Wang XK
    J Oral Maxillofac Surg; 2016 Nov; 74(11):2193-2199. PubMed ID: 27235180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propranolol for severe infantile hemangiomas: follow-up report.
    Sans V; de la Roque ED; Berge J; Grenier N; Boralevi F; Mazereeuw-Hautier J; Lipsker D; Dupuis E; Ezzedine K; Vergnes P; Taïeb A; Léauté-Labrèze C
    Pediatrics; 2009 Sep; 124(3):e423-31. PubMed ID: 19706583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe infantile hemangiomas with propranolol: an evaluation of the efficacy and effects of cardiovascular parameters in 25 consecutive patients.
    Xu DP; Cao RY; Xue L; Sun NN; Tong S; Wang XK
    J Oral Maxillofac Surg; 2015 Mar; 73(3):430-6. PubMed ID: 25544304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of propranolol for complicated infantile hemangiomas.
    Vercellino N; Romanini MV; Pelegrini M; Rimini A; Occella C; Dalmonte P
    Int J Dermatol; 2013 Sep; 52(9):1140-6. PubMed ID: 23829783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.
    Buckmiller LM; Munson PD; Dyamenahalli U; Dai Y; Richter GT
    Laryngoscope; 2010 Apr; 120(4):676-81. PubMed ID: 20112413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outpatient treatment of infantile hemangiomas with propranolol: a prospective study.
    Betlloch-Mas I; Martínez-Miravete MT; Lucas-Costa A; Martin de Lara AI; Selva-Otalaurruchi J
    Actas Dermosifiliogr; 2012 Nov; 103(9):806-15. PubMed ID: 22727954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of intralesional propranolol in infantile hemangiomas.
    Torres-Pradilla M; Baselga E
    Pediatr Dermatol; 2014; 31(2):156-8. PubMed ID: 24000875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of propranolol for infantile hemangiomas.
    Küpeli S
    Pediatr Hematol Oncol; 2012 Apr; 29(3):293-8. PubMed ID: 22303875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.
    Zvulunov A; McCuaig C; Frieden IJ; Mancini AJ; Puttgen KB; Dohil M; Fischer G; Powell J; Cohen B; Ben Amitai D
    Pediatr Dermatol; 2011; 28(2):94-8. PubMed ID: 21362031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol in the management of airway infantile hemangiomas.
    Rosbe KW; Suh KY; Meyer AK; Maguiness SM; Frieden IJ
    Arch Otolaryngol Head Neck Surg; 2010 Jul; 136(7):658-65. PubMed ID: 20644059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.